“Tissue-Engineered ‘Metastases’: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist ” (2021) Journal of Cancer Research Updates, 1(1), pp. 69–77. doi:10.6000/1929-2279.2012.01.01.11.